Atenolol
Generic name: Pronounced as (a ten' oh lole)
Medical Content Reviewed By HelloPharmacist Staff
Last Revised - 10/15/2017
On this page
- Why is this medication prescribed?
- How should this medicine be used?
- Other uses for this medicine
- What special precautions should I follow?
- What special dietary instructions should I follow?
- What should I do if I forget a dose?
- What side effects can this medication cause?
- What should I know about STORAGE and DISPOSAL of this medication?
- What should I do in case of OVERDOSE?
- What OTHER INFORMATION should I know?
- Brand names of combination products
- Drug interactions
IMPORTANT WARNING
Do not stop taking atenolol without talking to your doctor. Suddenly stopping atenolol may cause chest pain, heart attack, or irregular heartbeat. Your doctor will probably decrease your dose gradually.
Why is this medication prescribed?
Atenolol is used alone or in combination with other medications to treat high blood pressure. It also is used to prevent angina (chest pain) and improve survival after a heart attack. Atenolol is in a class of medications called beta blockers. It works by relaxing blood vessels and slowing heart rate to improve blood flow and decrease blood pressure.
High blood pressure is a common condition and when not treated, can cause damage to the brain, heart, blood vessels, kidneys and other parts of the body. Damage to these organs may cause heart disease, a heart attack, heart failure, stroke, kidney failure, loss of vision, and other problems. In addition to taking medication, making lifestyle changes will also help to control your blood pressure. These changes include eating a diet that is low in fat and salt, maintaining a healthy weight, exercising at least 30 minutes most days, not smoking, and using alcohol in moderation.
How should this medicine be used?
Atenolol comes as a tablet to take by mouth. It is usually taken once or twice a day. To help you remember to take atenolol, take it around the same time(s) every day. Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand. Take atenolol exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor.
Atenolol controls high blood pressure and angina but does not cure them. It may take 1-2 weeks before you feel the full benefit of atenolol. Continue to take atenolol even if you feel well. Do not stop taking atenolol without talking to your doctor.
Other uses for this medicine
Atenolol is also used sometimes to prevent migraine headaches and to treat alcohol withdrawal, heart failure, and irregular heartbeat. Talk to your doctor about the possible risks of using this medication for your condition.
This medication may be prescribed for other uses; ask your doctor or pharmacist for more information.
What special precautions should I follow?
Before taking atenolol,
-
tell your doctor and pharmacist if you are allergic to atenolol, any other medications, or any of the ingredients in atenolol tablets. Ask your pharmacist for a list of the ingredients.
-
tell your doctor and pharmacist what prescription and nonprescription medications, vitamins, nutritional supplements, and herbal products you are taking. Be sure to mention any of the following: calcium channel blockers such as diltiazem (Cardizem, Cartia XT, Dilacor XR, Tiazac, others) and verapamil (Calan, Covera-HS, Verelan, in Tarka); clonidine (Catapres, Kapvay, in Clorpres); nonsteroidal anti-inflammatory drugs (NSAIDs) such as indomethacin (Indocin, Tivorbex); and reserpine. Your doctor may need to change the doses of your medications or monitor you carefully for side effects.
-
tell your doctor if you have or have ever had asthma or other lung diseases; diabetes; severe allergies; hyperthyroidism (an overactive thyroid gland); pheochromocytoma (a tumor that develops on a gland near the kidneys and may cause high blood pressure and fast heartbeat); heart failure; a slow heart rate; circulation problems; or heart or kidney disease.
-
tell your doctor if you are pregnant, plan to become pregnant, or are breast-feeding. If you become pregnant while taking atenolol, call your doctor immediately.
-
if you are having surgery, including dental surgery, tell the doctor or dentist that you are taking atenolol.
-
you should know that if you have allergic reactions to different substances, your reactions may be worse while you are using atenolol, and your allergic reactions may not respond to the usual doses of injectable epinephrine.
What special dietary instructions should I follow?
If your doctor prescribes a low-salt or low-sodium diet, follow these directions carefully.
What should I do if I forget a dose?
Take the missed dose as soon as you remember it. However, if it is almost time for the next dose, skip the missed dose and continue your regular dosing schedule. Do not take a double dose to make up for a missed one.
What side effects can this medication cause?
-
Atenolol may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away:
-
dizziness
-
lightheadedness
-
tiredness
-
drowsiness
-
depression
-
nausea
-
diarrhea
-
-
Some side effects can be serious. The following symptoms are uncommon, but if you experience any of them, call your doctor immediately:
-
shortness of breath
-
swelling of the hands, feet, ankles, or lower legs
-
weight gain
-
fainting
-
-
Atenolol may cause other side effects. Call your doctor if you have any unusual problems while taking this medication.
-
If you experience a serious side effect, you or your doctor may send a report to the Food and Drug Administration's (FDA) MedWatch Adverse Event Reporting program online (http://www.fda.gov/Safety/MedWatch) or by phone (1-800-332-1088).
What should I know about STORAGE and DISPOSAL of this medication?
Keep this medication in the container it came in, tightly closed, and out of reach of children. Store it at room temperature and away from excess heat and moisture (not in the bathroom).
It is important to keep all medication out of sight and reach of children as many containers (such as weekly pill minders and those for eye drops, creams, patches, and inhalers) are not child-resistant and young children can open them easily. To protect young children from poisoning, always lock safety caps and immediately place the medication in a safe location – one that is up and away and out of their sight and reach. http://www.upandaway.org
Unneeded medications should be disposed of in special ways to ensure that pets, children, and other people cannot consume them. However, you should not flush this medication down the toilet. Instead, the best way to dispose of your medication is through a medicine take-back program. Talk to your pharmacist or contact your local garbage/recycling department to learn about take-back programs in your community. See the FDA's Safe Disposal of Medicines website (http://goo.gl/c4Rm4p) for more information if you do not have access to a take-back program.
What should I do in case of OVERDOSE?
In case of overdose, call the poison control helpline at 1-800-222-1222. Information is also available online at https://www.poisonhelp.org/help. If the victim has collapsed, had a seizure, has trouble breathing, or can't be awakened, immediately call emergency services at 911.
Symptoms of overdose may include:
-
lack of energy
-
difficulty breathing
-
wheezing
-
slow heartbeat
-
fainting
-
swelling of the hands, feet, ankles, or lower legs
-
unusual weight gain
-
shakiness
-
dizziness
-
rapid heartbeat
-
sweating or confusion
-
blurred vision
-
headache
-
numbness or tingling of the mouth
-
weakness
-
excessive tiredness
-
pale color
-
sudden hunger
What OTHER INFORMATION should I know?
Keep all appointments with your doctor. Your blood pressure should be checked regularly to determine your response to atenolol. Your doctor may ask you to check your pulse (heart rate). Ask your pharmacist or doctor to teach you how to take your pulse. If your pulse is faster or slower than it should be, call your doctor.
Do not let anyone else take your medication. Ask your pharmacist any questions you have about refilling your prescription.
It is important for you to keep a written list of all of the prescription and nonprescription (over-the-counter) medicines you are taking, as well as any products such as vitamins, minerals, or other dietary supplements. You should bring this list with you each time you visit a doctor or if you are admitted to a hospital. It is also important information to carry with you in case of emergencies.
Drug interactions
Drug | Interaction |
---|---|
Repaglinide | Repaglinide The therapeutic efficacy of Repaglinide can be increased when used in combination with Atenolol. |
Insulin Glargine (rDNA origin) Injection | Insulin Glargine (rDNA origin) Injection The therapeutic efficacy of Insulin glargine can be increased when used in combination with Atenolol. |
Delavirdine | Delavirdine The metabolism of Atenolol can be decreased when combined with Delavirdine. |
Nevirapine | Nevirapine The metabolism of Atenolol can be decreased when combined with Nevirapine. |
Atorvastatin | Atorvastatin Atenolol may decrease the excretion rate of Atorvastatin which could result in a higher serum level. |
Dolasetron | Dolasetron The metabolism of Dolasetron can be decreased when combined with Atenolol. |
Aminophylline | Aminophylline The risk or severity of adverse effects can be increased when Atenolol is combined with Aminophylline. |
Calcium Carbonate | Calcium Carbonate The therapeutic efficacy of Atenolol can be decreased when used in combination with Calcium carbonate. |
Candesartan | Candesartan The risk or severity of hyperkalemia can be increased when Atenolol is combined with Candesartan. |
Cilostazol | Cilostazol The metabolism of Cilostazol can be decreased when combined with Atenolol. |
Erythromycin and Sulfisoxazole | Erythromycin and Sulfisoxazole Erythromycin may decrease the excretion rate of Atenolol which could result in a higher serum level. |
Fenofibrate | Fenofibrate Atenolol may decrease the excretion rate of Fenofibrate which could result in a higher serum level. |
Guanfacine | Guanfacine The therapeutic efficacy of Guanfacine can be decreased when used in combination with Atenolol. |
Methylergonovine | Methylergonovine Atenolol may increase the vasoconstricting activities of Methylergometrine. |
Miglitol | Miglitol The therapeutic efficacy of Miglitol can be increased when used in combination with Atenolol. |
Naratriptan | Naratriptan Naratriptan may decrease the antihypertensive activities of Atenolol. |
Olsalazine | Olsalazine Olsalazine may decrease the antihypertensive activities of Atenolol. |
Paregoric | Paregoric The risk or severity of adverse effects can be increased when Morphine is combined with Atenolol. |
Penbutolol | Penbutolol Acebutolol may increase the arrhythmogenic activities of Atenolol. |
Potassium | Potassium Potassium may increase the hyperkalemic activities of Atenolol. |
Ranitidine | Ranitidine The metabolism of Atenolol can be decreased when combined with Ranitidine. |
Reserpine | Reserpine Reserpine may increase the hypotensive activities of Atenolol. |
Rizatriptan | Rizatriptan Rizatriptan may decrease the antihypertensive activities of Atenolol. |
Sumatriptan | Sumatriptan Sumatriptan may decrease the antihypertensive activities of Atenolol. |
Tacrolimus | Tacrolimus The risk or severity of hyperkalemia can be increased when Atenolol is combined with Tacrolimus. |
Tizanidine | Tizanidine The therapeutic efficacy of Tizanidine can be decreased when used in combination with Atenolol. |
Zolmitriptan | Zolmitriptan Zolmitriptan may decrease the antihypertensive activities of Atenolol. |
Ampicillin Injection | Ampicillin Injection The bioavailability of Atenolol can be decreased when combined with Ampicillin. |
Fluconazole Injection | Fluconazole Injection The risk or severity of hyperkalemia can be increased when Fluconazole is combined with Atenolol. |
Meperidine Injection | Meperidine Injection The metabolism of Meperidine can be decreased when combined with Atenolol. |
Metoclopramide Injection | Metoclopramide Injection The metabolism of Atenolol can be decreased when combined with Metoclopramide. |
Morphine Injection | Morphine Injection The risk or severity of adverse effects can be increased when Morphine is combined with Atenolol. |
Altretamine | Altretamine The therapeutic efficacy of Atenolol can be decreased when used in combination with Amphetamine. |
Cyclosporine | Cyclosporine The metabolism of Atenolol can be decreased when combined with Cyclosporine. |
Ondansetron | Ondansetron The metabolism of Ondansetron can be decreased when combined with Atenolol. |
Enoxaparin Injection | Enoxaparin Injection The risk or severity of hyperkalemia can be increased when Atenolol is combined with Enoxaparin. |
Torsemide | Torsemide Torasemide may increase the hypotensive activities of Atenolol. |
Olanzapine | Olanzapine Atenolol may increase the orthostatic hypotensive activities of Olanzapine. |
Dofetilide | Dofetilide Dofetilide may increase the arrhythmogenic activities of Atenolol. |
Entacapone | Entacapone The metabolism of Atenolol can be decreased when combined with Entacapone. |
Eprosartan | Eprosartan The risk or severity of hyperkalemia can be increased when Atenolol is combined with Eprosartan. |
Hydroxychloroquine | Hydroxychloroquine The risk or severity of QTc prolongation can be decreased when Hydroxychloroquine is combined with Atenolol. |
Meloxicam | Meloxicam Meloxicam may decrease the antihypertensive activities of Atenolol. |
Telmisartan | Telmisartan Atenolol may decrease the excretion rate of Telmisartan which could result in a higher serum level. |
Anakinra | Anakinra The metabolism of Atenolol can be increased when combined with Anakinra. |
Linezolid | Linezolid Linezolid may increase the hypotensive activities of Atenolol. |
Rivastigmine | Rivastigmine Atenolol may increase the bradycardic activities of Rivastigmine. |
Trimipramine | Trimipramine The metabolism of Atenolol can be decreased when combined with Trimipramine. |
Etanercept Injection | Etanercept Injection The metabolism of Atenolol can be increased when combined with Etanercept. |
Glycopyrrolate | Glycopyrrolate The bioavailability of Atenolol can be increased when combined with Glycopyrronium. |
Perindopril | Perindopril Atenolol may increase the hypotensive activities of Perindopril. |
Choline Magnesium Trisalicylate | Choline Magnesium Trisalicylate Choline magnesium trisalicylate may decrease the antihypertensive activities of Atenolol. |
Dutasteride | Dutasteride Dutasteride may decrease the antihypertensive activities of Atenolol. |
Epinephrine Injection | Epinephrine Injection The therapeutic efficacy of Epinephrine can be decreased when used in combination with Atenolol. |
Eplerenone | Eplerenone The risk or severity of hyperkalemia can be increased when Atenolol is combined with Eplerenone. |
Escitalopram | Escitalopram The serum concentration of Atenolol can be increased when it is combined with Escitalopram. |
Olmesartan | Olmesartan Olmesartan may decrease the excretion rate of Atenolol which could result in a higher serum level. |
Zonisamide | Zonisamide The risk or severity of bradycardia can be increased when Zonisamide is combined with Atenolol. |
Adalimumab Injection | Adalimumab Injection The metabolism of Atenolol can be increased when combined with Adalimumab. |
Aripiprazole | Aripiprazole The risk or severity of hypotension can be increased when Aripiprazole is combined with Atenolol. |
Atomoxetine | Atomoxetine The metabolism of Atenolol can be decreased when combined with Atomoxetine. |
Dexmethylphenidate | Dexmethylphenidate Dexmethylphenidate may decrease the antihypertensive activities of Atenolol. |
Ezetimibe | Ezetimibe Atenolol may decrease the excretion rate of Ezetimibe which could result in a higher serum level. |
Atazanavir | Atazanavir Atenolol may decrease the excretion rate of Atazanavir which could result in a higher serum level. |
Almotriptan | Almotriptan The metabolism of Almotriptan can be decreased when combined with Atenolol. |
Eletriptan | Eletriptan Eletriptan may decrease the antihypertensive activities of Atenolol. |
Mefloquine | Mefloquine The risk or severity of QTc prolongation can be decreased when Mefloquine is combined with Atenolol. |
Rosuvastatin | Rosuvastatin Atenolol may decrease the excretion rate of Rosuvastatin which could result in a higher serum level. |
Vardenafil | Vardenafil Vardenafil may increase the antihypertensive activities of Atenolol. |
Alfuzosin | Alfuzosin Alfuzosin may increase the hypotensive activities of Atenolol. |
Memantine | Memantine Memantine may increase the bradycardic activities of Atenolol. |
Tegaserod | Tegaserod The metabolism of Atenolol can be decreased when combined with Tegaserod. |
Tadalafil | Tadalafil Tadalafil may increase the antihypertensive activities of Atenolol. |
Frovatriptan | Frovatriptan Frovatriptan may decrease the antihypertensive activities of Atenolol. |
Progesterone | Progesterone Progesterone may decrease the excretion rate of Atenolol which could result in a higher serum level. |
Apomorphine Injection | Apomorphine Injection The risk or severity of adverse effects can be increased when Apomorphine is combined with Atenolol. |
Infliximab Injection | Infliximab Injection The metabolism of Atenolol can be increased when combined with Infliximab. |
Protriptyline | Protriptyline Protriptyline may decrease the antihypertensive activities of Atenolol. |
Rifaximin | Rifaximin The metabolism of Atenolol can be increased when combined with Rifaximin. |
Duloxetine | Duloxetine The risk or severity of orthostatic hypotension and syncope can be increased when Atenolol is combined with Duloxetine. |
Tinidazole | Tinidazole Atenolol may decrease the excretion rate of Tinidazole which could result in a higher serum level. |
Trospium | Trospium The metabolism of Atenolol can be decreased when combined with Trospium. |
Bosentan | Bosentan Bosentan may decrease the excretion rate of Atenolol which could result in a higher serum level. |
Cinacalcet | Cinacalcet The metabolism of Atenolol can be decreased when combined with Cinacalcet. |
Erlotinib | Erlotinib The metabolism of Erlotinib can be decreased when combined with Atenolol. |
Insulin Aspart (rDNA Origin) Injection | Insulin Aspart (rDNA Origin) Injection The therapeutic efficacy of Insulin aspart can be increased when used in combination with Atenolol. |
Solifenacin | Solifenacin Solifenacin may decrease the antihypertensive activities of Atenolol. |
Dextroamphetamine | Dextroamphetamine The therapeutic efficacy of Atenolol can be decreased when used in combination with Amphetamine. |
Peginterferon Alfa-2b (PEG-Intron) | Peginterferon Alfa-2b (PEG-Intron) The metabolism of Atenolol can be decreased when combined with Peginterferon alfa-2b. |
Pramlintide Injection | Pramlintide Injection The therapeutic efficacy of Pramlintide can be increased when used in combination with Atenolol. |
Exenatide Injection | Exenatide Injection The therapeutic efficacy of Exenatide can be increased when used in combination with Atenolol. |
Isocarboxazid | Isocarboxazid Isocarboxazid may increase the hypotensive activities of Atenolol. |
Darifenacin | Darifenacin The metabolism of Atenolol can be decreased when combined with Darifenacin. |
Fentanyl | Fentanyl Fentanyl may decrease the antihypertensive activities of Atenolol. |
Pregabalin | Pregabalin Pregabalin may increase the arrhythmogenic activities of Atenolol. |
Phenylephrine | Phenylephrine The therapeutic efficacy of Phenylephrine can be decreased when used in combination with Atenolol. |
Tipranavir | Tipranavir The metabolism of Atenolol can be decreased when combined with Tipranavir. |
Insulin Detemir (rDNA Origin) Injection | Insulin Detemir (rDNA Origin) Injection The therapeutic efficacy of Insulin detemir can be increased when used in combination with Atenolol. |
Ranolazine | Ranolazine The serum concentration of Atenolol can be increased when it is combined with Ranolazine. |
Abatacept Injection | Abatacept Injection The metabolism of Atenolol can be increased when combined with Abatacept. |
Rasagiline | Rasagiline Rasagiline may increase the hypotensive activities of Atenolol. |
Imatinib | Imatinib Atenolol may decrease the excretion rate of Imatinib which could result in a higher serum level. |
Sitagliptin | Sitagliptin The therapeutic efficacy of Sitagliptin can be increased when used in combination with Atenolol. |
Varenicline | Varenicline The risk or severity of adverse effects can be increased when Atenolol is combined with Varenicline. |
Gefitinib | Gefitinib The metabolism of Atenolol can be decreased when combined with Gefitinib. |
Albuterol | Albuterol The therapeutic efficacy of Salbutamol can be decreased when used in combination with Atenolol. |
Paliperidone | Paliperidone Atenolol may increase the orthostatic hypotensive activities of Paliperidone. |
Bortezomib | Bortezomib The metabolism of Atenolol can be decreased when combined with Bortezomib. |
Clofarabine Injection | Clofarabine Injection The risk or severity of adverse effects can be increased when Clofarabine is combined with Atenolol. |
Insulin Glulisine (rDNA origin) Injection | Insulin Glulisine (rDNA origin) Injection The therapeutic efficacy of Insulin glulisine can be increased when used in combination with Atenolol. |
Primaquine | Primaquine The metabolism of Atenolol can be decreased when combined with Primaquine. |
Rituximab Injection | Rituximab Injection Atenolol may increase the hypotensive activities of Rituximab. |
Aliskiren | Aliskiren The risk or severity of hyperkalemia can be increased when Atenolol is combined with Aliskiren. |
Lisdexamfetamine | Lisdexamfetamine The therapeutic efficacy of Atenolol can be decreased when used in combination with Lisdexamfetamine. |
Nabilone | Nabilone The risk or severity of adverse effects can be increased when Nabilone is combined with Atenolol. |
Sorafenib | Sorafenib The metabolism of Atenolol can be decreased when combined with Sorafenib. |
Sunitinib | Sunitinib The therapeutic efficacy of Sunitinib can be increased when used in combination with Atenolol. |
Mexiletine | Mexiletine Atenolol may increase the arrhythmogenic activities of Mexiletine. |
Temsirolimus | Temsirolimus The metabolism of Atenolol can be decreased when combined with Temsirolimus. |
Nilotinib | Nilotinib The metabolism of Atenolol can be decreased when combined with Nilotinib. |
Budesonide | Budesonide Atenolol may decrease the excretion rate of Budesonide which could result in a higher serum level. |
Desmopressin | Desmopressin Desmopressin may decrease the antihypertensive activities of Atenolol. |
Betaine | Betaine Glycine betaine may increase the bradycardic activities of Atenolol. |
Arsenic Trioxide Injection | Arsenic Trioxide Injection The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Atenolol. |
Desvenlafaxine | Desvenlafaxine The serum concentration of Atenolol can be increased when it is combined with Desvenlafaxine. |
Cevimeline | Cevimeline The risk or severity of adverse effects can be increased when Atenolol is combined with Cevimeline. |
Nebivolol | Nebivolol Atenolol may increase the arrhythmogenic activities of Nebivolol. |
Tretinoin | Tretinoin The risk or severity of adverse effects can be increased when Tretinoin is combined with Atenolol. |
Pilocarpine | Pilocarpine The risk or severity of adverse effects can be increased when Atenolol is combined with Pilocarpine. |
Flecainide | Flecainide Atenolol may increase the arrhythmogenic activities of Flecainide. |
Certolizumab Injection | Certolizumab Injection The metabolism of Atenolol can be increased when combined with Certolizumab pegol. |
Silodosin | Silodosin Atenolol may increase the orthostatic hypotensive activities of Silodosin. |
Milnacipran | Milnacipran The serum concentration of Atenolol can be increased when it is combined with Milnacipran. |
Sodium Phosphate | Sodium Phosphate Sodium phosphate, monobasic may increase the hyperkalemic activities of Atenolol. |
Fesoterodine | Fesoterodine The metabolism of Fesoterodine can be decreased when combined with Atenolol. |
Betaxolol | Betaxolol Betaxolol may increase the arrhythmogenic activities of Atenolol. |
Iloperidone | Iloperidone Atenolol may increase the orthostatic hypotensive activities of Iloperidone. |
Lacosamide | Lacosamide Atenolol may increase the bradycardic activities of Lacosamide. |
Everolimus | Everolimus The metabolism of Atenolol can be decreased when combined with Everolimus. |
Tolvaptan (low blood sodium) | Tolvaptan (low blood sodium) The risk or severity of hyperkalemia can be increased when Atenolol is combined with Tolvaptan. |
Dronedarone | Dronedarone Dronedarone may increase the bradycardic activities of Atenolol. |
Palonosetron Injection | Palonosetron Injection The metabolism of Palonosetron can be decreased when combined with Atenolol. |
Saxagliptin | Saxagliptin The therapeutic efficacy of Saxagliptin can be increased when used in combination with Atenolol. |
Tapentadol | Tapentadol The metabolism of Atenolol can be decreased when combined with Tapentadol. |
Golimumab Injection | Golimumab Injection The metabolism of Atenolol can be increased when combined with Golimumab. |
Pazopanib | Pazopanib The metabolism of Pazopanib can be decreased when combined with Atenolol. |
Asenapine | Asenapine Atenolol may increase the orthostatic hypotensive activities of Asenapine. |
Pitavastatin | Pitavastatin Atenolol may decrease the excretion rate of Pitavastatin which could result in a higher serum level. |
Oxymorphone | Oxymorphone The metabolism of Oxymorphone can be decreased when combined with Atenolol. |
Liraglutide Injection | Liraglutide Injection The therapeutic efficacy of Liraglutide can be increased when used in combination with Atenolol. |
Tocilizumab Injection | Tocilizumab Injection The metabolism of Atenolol can be increased when combined with Tocilizumab. |
Fingolimod | Fingolimod Atenolol may increase the bradycardic activities of Fingolimod. |
Lurasidone | Lurasidone Lurasidone may decrease the antihypertensive activities of Atenolol. |
Acetaminophen Injection | Acetaminophen Injection The metabolism of Atenolol can be decreased when combined with Acetaminophen. |
Vilazodone | Vilazodone The metabolism of Atenolol can be decreased when combined with Vilazodone. |
Denileukin Diftitox Injection | Denileukin Diftitox Injection The risk or severity of adverse effects can be increased when Aldesleukin is combined with Atenolol. |
Terbutaline Injection | Terbutaline Injection The therapeutic efficacy of Terbutaline can be decreased when used in combination with Atenolol. |
Azilsartan | Azilsartan The risk or severity of hyperkalemia can be increased when Atenolol is combined with Azilsartan medoxomil. |
Linagliptin | Linagliptin The therapeutic efficacy of Linagliptin can be increased when used in combination with Atenolol. |
Rilpivirine | Rilpivirine The metabolism of Atenolol can be decreased when combined with Rilpivirine. |
Potassium Iodide | Potassium Iodide Potassium Iodide may increase the hyperkalemic activities of Atenolol. |
Abiraterone | Abiraterone The metabolism of Atenolol can be decreased when combined with Abiraterone. |
Ruxolitinib | Ruxolitinib Ruxolitinib may increase the bradycardic activities of Atenolol. |
Clobazam | Clobazam The metabolism of Atenolol can be decreased when combined with Clobazam. |
Vemurafenib | Vemurafenib The metabolism of Atenolol can be decreased when combined with Vemurafenib. |
Crizotinib | Crizotinib Atenolol may increase the bradycardic activities of Crizotinib. |
Cabergoline | Cabergoline Atenolol may increase the vasoconstricting activities of Cabergoline. |
Ambrisentan | Ambrisentan Atenolol may increase the hypotensive activities of Ambrisentan. |
Iloprost | Iloprost Iloprost may increase the hypotensive activities of Atenolol. |
Mirabegron | Mirabegron The metabolism of Mirabegron can be decreased when combined with Atenolol. |
Regorafenib | Regorafenib Regorafenib may increase the bradycardic activities of Atenolol. |
Lorcaserin | Lorcaserin The therapeutic efficacy of Mecasermin can be increased when used in combination with Atenolol. |
Tofacitinib | Tofacitinib Atenolol may increase the bradycardic activities of Tofacitinib. |
Alogliptin | Alogliptin The therapeutic efficacy of Alogliptin can be increased when used in combination with Atenolol. |
Ponatinib | Ponatinib The metabolism of Ponatinib can be decreased when combined with Atenolol. |
Canagliflozin | Canagliflozin The therapeutic efficacy of Canagliflozin can be increased when used in combination with Atenolol. |
Methazolamide | Methazolamide The risk or severity of adverse effects can be increased when Methazolamide is combined with Atenolol. |
Ospemifene | Ospemifene The metabolism of Atenolol can be decreased when combined with Ospemifene. |
Levomilnacipran | Levomilnacipran The serum concentration of Atenolol can be increased when it is combined with Levomilnacipran. |
Vortioxetine | Vortioxetine The metabolism of Vortioxetine can be decreased when combined with Atenolol. |
Ibrutinib | Ibrutinib The metabolism of Ibrutinib can be decreased when combined with Atenolol. |
Avanafil | Avanafil Avanafil may increase the antihypertensive activities of Atenolol. |
Ketorolac Injection | Ketorolac Injection Ketorolac may decrease the antihypertensive activities of Atenolol. |
Obinutuzumab Injection | Obinutuzumab Injection Atenolol may increase the hypotensive activities of Obinutuzumab. |
Simeprevir | Simeprevir Simeprevir may decrease the excretion rate of Atenolol which could result in a higher serum level. |
Dapagliflozin | Dapagliflozin The therapeutic efficacy of Atenolol can be increased when used in combination with Dapagliflozin. |
Apremilast | Apremilast The metabolism of Atenolol can be increased when combined with Apremilast. |
Droxidopa | Droxidopa The therapeutic efficacy of Droxidopa can be decreased when used in combination with Atenolol. |
Ceritinib | Ceritinib Atenolol may increase the bradycardic activities of Ceritinib. |
Siltuximab Injection | Siltuximab Injection The metabolism of Atenolol can be increased when combined with Siltuximab. |
Albiglutide Injection | Albiglutide Injection The therapeutic efficacy of Albiglutide can be increased when used in combination with Atenolol. |
Oritavancin Injection | Oritavancin Injection The metabolism of Atenolol can be decreased when combined with Oritavancin. |
Empagliflozin | Empagliflozin The therapeutic efficacy of Atenolol can be increased when used in combination with Empagliflozin. |
Dulaglutide Injection | Dulaglutide Injection The therapeutic efficacy of Dulaglutide can be increased when used in combination with Atenolol. |
Methamphetamine | Methamphetamine The therapeutic efficacy of Atenolol can be decreased when used in combination with Metamfetamine. |
Riociguat | Riociguat Atenolol may increase the hypotensive activities of Riociguat. |
Lanreotide Injection | Lanreotide Injection Atenolol may increase the bradycardic activities of Lanreotide. |
Secukinumab Injection | Secukinumab Injection The metabolism of Atenolol can be increased when combined with Secukinumab. |
Risperidone Injection | Risperidone Injection Atenolol may increase the hypotensive activities of Risperidone. |
Insulin Human Inhalation | Insulin Human Inhalation The therapeutic efficacy of Insulin human can be increased when used in combination with Atenolol. |
Lenvatinib | Lenvatinib Lenvatinib may decrease the excretion rate of Atenolol which could result in a higher serum level. |
Naloxegol | Naloxegol The metabolism of Atenolol can be decreased when combined with Naloxegol. |
Panobinostat | Panobinostat The metabolism of Atenolol can be decreased when combined with Panobinostat. |
Dinutuximab Injection | Dinutuximab Injection The risk or severity of adverse effects can be increased when Dinutuximab is combined with Atenolol. |
Haloperidol Injection | Haloperidol Injection The serum concentration of Atenolol can be increased when it is combined with Haloperidol. |
Deoxycholic Acid Injection | Deoxycholic Acid Injection Deoxycholic acid may increase the excretion rate of Atenolol which could result in a lower serum level and potentially a reduction in efficacy. |
Ivabradine | Ivabradine Atenolol may increase the bradycardic activities of Ivabradine. |
Amiloride | Amiloride The risk or severity of hyperkalemia can be increased when Atenolol is combined with Amiloride. |
Macitentan | Macitentan Atenolol may increase the hypotensive activities of Macitentan. |
Flibanserin | Flibanserin Flibanserin may decrease the antihypertensive activities of Atenolol. |
Rolapitant | Rolapitant The metabolism of Atenolol can be decreased when combined with Rolapitant. |
Brexpiprazole | Brexpiprazole Atenolol may increase the orthostatic hypotensive activities of Brexpiprazole. |
Ziprasidone Injection | Ziprasidone Injection Atenolol may increase the antihypertensive activities of Ziprasidone. |
Cariprazine | Cariprazine The metabolism of Cariprazine can be decreased when combined with Atenolol. |
Insulin Degludec (rDNA Origin) Injection | Insulin Degludec (rDNA Origin) Injection The therapeutic efficacy of Insulin degludec can be increased when used in combination with Atenolol. |
Trabectedin Injection | Trabectedin Injection The metabolism of Trabectedin can be decreased when combined with Atenolol. |
Rifapentine | Rifapentine The metabolism of Atenolol can be increased when combined with Rifapentine. |
Amphotericin B Liposomal Injection | Amphotericin B Liposomal Injection The risk or severity of adverse effects can be increased when Amphotericin B is combined with Atenolol. |
Dexamethasone Injection | Dexamethasone Injection Dexamethasone may increase the excretion rate of Atenolol which could result in a lower serum level and potentially a reduction in efficacy. |
Cobicistat | Cobicistat The metabolism of Atenolol can be decreased when combined with Cobicistat. |
Midodrine | Midodrine The therapeutic efficacy of Midodrine can be decreased when used in combination with Atenolol. |
Selexipag | Selexipag Atenolol may increase the hypotensive activities of Selexipag. |
Diphenhydramine Injection | Diphenhydramine Injection The metabolism of Atenolol can be decreased when combined with Diphenhydramine. |
Furosemide Injection | Furosemide Injection Furosemide may increase the hypotensive activities of Atenolol. |
Rucaparib | Rucaparib The metabolism of Atenolol can be decreased when combined with Rucaparib. |
Lixisenatide Injection | Lixisenatide Injection The therapeutic efficacy of Lixisenatide can be increased when used in combination with Atenolol. |
Doxepin (Insomnia) | Doxepin (Insomnia) The metabolism of Atenolol can be decreased when combined with Doxepin. |
Deutetrabenazine | Deutetrabenazine The metabolism of Deutetrabenazine can be decreased when combined with Atenolol. |
Valbenazine | Valbenazine The metabolism of Valbenazine can be decreased when combined with Atenolol. |
Safinamide | Safinamide Safinamide may increase the hypotensive activities of Atenolol. |
Midostaurin | Midostaurin The metabolism of Atenolol can be decreased when combined with Midostaurin. |
Enasidenib | Enasidenib The metabolism of Atenolol can be decreased when combined with Enasidenib. |
Letermovir | Letermovir Letermovir may decrease the excretion rate of Atenolol which could result in a higher serum level. |
Semaglutide Injection | Semaglutide Injection The therapeutic efficacy of Semaglutide can be increased when used in combination with Atenolol. |
Tetrabenazine | Tetrabenazine The metabolism of Tetrabenazine can be decreased when combined with Atenolol. |
Ertugliflozin | Ertugliflozin The therapeutic efficacy of Ertugliflozin can be increased when used in combination with Atenolol. |
Buprenorphine Injection | Buprenorphine Injection The metabolism of Atenolol can be decreased when combined with Buprenorphine. |
Fostamatinib | Fostamatinib Fostamatinib may increase the antihypertensive activities of Atenolol. |
Lofexidine | Lofexidine The therapeutic efficacy of Lofexidine can be decreased when used in combination with Atenolol. |
Eliglustat | Eliglustat The metabolism of Eliglustat can be decreased when combined with Atenolol. |
Encorafenib | Encorafenib The metabolism of Encorafenib can be decreased when combined with Atenolol. |
Elagolix | Elagolix The metabolism of Elagolix can be decreased when combined with Atenolol. |
Tafenoquine | Tafenoquine The metabolism of Tafenoquine can be decreased when combined with Atenolol. |
Cannabidiol | Cannabidiol The metabolism of Atenolol can be decreased when combined with Cannabidiol. |
Dacomitinib | Dacomitinib The metabolism of Atenolol can be decreased when combined with Dacomitinib. |
Stiripentol | Stiripentol The metabolism of Atenolol can be decreased when combined with Stiripentol. |
Paclitaxel (with albumin) Injection | Paclitaxel (with albumin) Injection Atenolol may decrease the excretion rate of Paclitaxel which could result in a higher serum level. |
Rifamycin | Rifamycin The metabolism of Atenolol can be increased when combined with Rifamycin. |
Emapalumab-lzsg Injection | Emapalumab-lzsg Injection The metabolism of Atenolol can be increased when combined with Emapalumab. |
Siponimod | Siponimod Siponimod may decrease the antihypertensive activities of Atenolol. |
Solriamfetol | Solriamfetol Solriamfetol may decrease the antihypertensive activities of Atenolol. |
Triclabendazole | Triclabendazole The metabolism of Atenolol can be decreased when combined with Triclabendazole. |
Istradefylline | Istradefylline The metabolism of Istradefylline can be decreased when combined with Atenolol. |
Pitolisant | Pitolisant The metabolism of Atenolol can be decreased when combined with Pitolisant. |
Fedratinib | Fedratinib The metabolism of Atenolol can be decreased when combined with Fedratinib. |
Phenytoin Injection | Phenytoin Injection The metabolism of Atenolol can be decreased when combined with Phenytoin. |
Lasmiditan | Lasmiditan Lasmiditan may increase the bradycardic activities of Atenolol. |
Calcium Acetate | Calcium Acetate The therapeutic efficacy of Atenolol can be decreased when used in combination with Calcium acetate. |
Selpercatinib | Selpercatinib Selpercatinib may decrease the antihypertensive activities of Atenolol. |
Fenfluramine | Fenfluramine The metabolism of Atenolol can be decreased when combined with Fenfluramine. |
Octreotide | Octreotide The serum concentration of the active metabolites of Atenolol can be increased when Atenolol is used in combination with Octreotide. |
Belantamab Mafodotin-blmf Injection | Belantamab Mafodotin-blmf Injection Atenolol may decrease the excretion rate of Belantamab mafodotin which could result in a higher serum level. |
Pralsetinib | Pralsetinib Pralsetinib may decrease the excretion rate of Atenolol which could result in a higher serum level. |
Naxitamab-gqgk Injection | Naxitamab-gqgk Injection Naxitamab may decrease the antihypertensive activities of Atenolol. |
Progestin-Only (drospirenone) Oral Contraceptives | Progestin-Only (drospirenone) Oral Contraceptives The risk or severity of hyperkalemia can be increased when Atenolol is combined with Drospirenone. |
Theophylline | Theophylline The metabolism of Theophylline can be decreased when combined with Atenolol. |
Fenoprofen | Fenoprofen Fenoprofen may decrease the antihypertensive activities of Atenolol. |
Indomethacin | Indomethacin Indomethacin may decrease the antihypertensive activities of Atenolol. |
Mefenamic Acid | Mefenamic Acid Mefenamic acid may decrease the antihypertensive activities of Atenolol. |
Naproxen | Naproxen Naproxen may decrease the antihypertensive activities of Atenolol. |
Tolmetin | Tolmetin Tolmetin may decrease the antihypertensive activities of Atenolol. |
Sulindac | Sulindac Sulindac may decrease the antihypertensive activities of Atenolol. |
Trazodone | Trazodone The serum concentration of Atenolol can be increased when it is combined with Trazodone. |
Hydroxyurea | Hydroxyurea The metabolism of Atenolol can be decreased when combined with Hydroxyurea. |
Phenobarbital | Phenobarbital The serum concentration of Atenolol can be decreased when it is combined with Phenobarbital. |
Primidone | Primidone The serum concentration of Atenolol can be decreased when it is combined with Primidone. |
Methsuximide | Methsuximide The risk or severity of bradycardia can be increased when Methsuximide is combined with Atenolol. |
Diethylpropion | Diethylpropion The therapeutic efficacy of Atenolol can be decreased when used in combination with Diethylpropion. |
Chlorpromazine | Chlorpromazine The metabolism of Atenolol can be decreased when combined with Chlorpromazine. |
Phenoxybenzamine | Phenoxybenzamine Atenolol may increase the orthostatic hypotensive activities of Phenoxybenzamine. |
Codeine | Codeine The metabolism of Atenolol can be decreased when combined with Codeine. |
Bromocriptine | Bromocriptine The therapeutic efficacy of Bromocriptine can be increased when used in combination with Atenolol. |
Metaproterenol | Metaproterenol The therapeutic efficacy of Orciprenaline can be decreased when used in combination with Atenolol. |
Tranylcypromine | Tranylcypromine The metabolism of Atenolol can be decreased when combined with Tranylcypromine. |
Phenelzine | Phenelzine Phenelzine may increase the hypotensive activities of Atenolol. |
Procarbazine | Procarbazine Procarbazine may increase the hypotensive activities of Atenolol. |
Ergoloid Mesylates | Ergoloid Mesylates Atenolol may increase the vasoconstricting activities of Ergoloid mesylate. |
Prochlorperazine | Prochlorperazine The serum concentration of Atenolol can be increased when it is combined with Prochlorperazine. |
Thioridazine | Thioridazine The metabolism of Atenolol can be decreased when combined with Thioridazine. |
Trifluoperazine | Trifluoperazine The serum concentration of Atenolol can be increased when it is combined with Trifluoperazine. |
Sulfadiazine | Sulfadiazine The therapeutic efficacy of Sulfadiazine can be increased when used in combination with Atenolol. |
Oxycodone | Oxycodone The metabolism of Oxycodone can be decreased when combined with Atenolol. |
Methadone | Methadone The metabolism of Atenolol can be decreased when combined with Methadone. |
Oxybutynin | Oxybutynin The metabolism of Atenolol can be decreased when combined with Oxybutynin. |
Benztropine | Benztropine The metabolism of Atenolol can be decreased when combined with Benzatropine. |
Maprotiline | Maprotiline The metabolism of Maprotiline can be decreased when combined with Atenolol. |
Ibuprofen | Ibuprofen Ibuprofen may decrease the antihypertensive activities of Atenolol. |
Orphenadrine | Orphenadrine The metabolism of Atenolol can be decreased when combined with Orphenadrine. |
Perphenazine | Perphenazine The serum concentration of Atenolol can be increased when it is combined with Perphenazine. |
Fluphenazine | Fluphenazine The serum concentration of Atenolol can be increased when it is combined with Fluphenazine. |
Phentermine | Phentermine The therapeutic efficacy of Atenolol can be decreased when used in combination with Phentermine. |
Methylphenidate | Methylphenidate Methylphenidate may decrease the antihypertensive activities of Atenolol. |
Amoxapine | Amoxapine The metabolism of Atenolol can be decreased when combined with Amoxapine. |
Sulfasalazine | Sulfasalazine Sulfasalazine may decrease the antihypertensive activities of Atenolol. |
Doxorubicin | Doxorubicin Doxorubicin may decrease the excretion rate of Atenolol which could result in a higher serum level. |
Mechlorethamine | Mechlorethamine Mechlorethamine may increase the bradycardic activities of Atenolol. |
Pyridostigmine | Pyridostigmine Pyridostigmine may increase the bradycardic activities of Atenolol. |
Methyldopa | Methyldopa The therapeutic efficacy of Methyldopa can be decreased when used in combination with Atenolol. |
Clonidine | Clonidine The risk or severity of hypotension can be increased when Clonidine is combined with Atenolol. |
Prazosin | Prazosin The risk or severity of hypotension can be increased when Prazosin is combined with Atenolol. |
Hydralazine | Hydralazine Atenolol may increase the hypotensive activities of Hydralazine. |
Cimetidine | Cimetidine The metabolism of Atenolol can be decreased when combined with Cimetidine. |
Loperamide | Loperamide The risk or severity of bradycardia can be increased when Loperamide is combined with Atenolol. |
Promethazine | Promethazine The serum concentration of Atenolol can be increased when it is combined with Promethazine. |
Meclofenamate | Meclofenamate Meclofenamic acid may decrease the antihypertensive activities of Atenolol. |
Daunorubicin | Daunorubicin Atenolol may decrease the excretion rate of Daunorubicin which could result in a higher serum level. |
Nitrofurantoin | Nitrofurantoin Atenolol may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level. |
Digoxin | Digoxin Atenolol may increase the arrhythmogenic activities of Digoxin. |
Chloroquine | Chloroquine The metabolism of Atenolol can be decreased when combined with Chloroquine. |
Quinine | Quinine The metabolism of Atenolol can be decreased when combined with Quinine. |
Ethosuximide | Ethosuximide The risk or severity of bradycardia can be increased when Ethosuximide is combined with Atenolol. |
Triamterene | Triamterene The risk or severity of hyperkalemia can be increased when Atenolol is combined with Triamterene. |
Sulfinpyrazone | Sulfinpyrazone Atenolol may decrease the excretion rate of Sulfinpyrazone which could result in a higher serum level. |
Chlorothiazide | Chlorothiazide The therapeutic efficacy of Chlorothiazide can be increased when used in combination with Atenolol. |
Metolazone | Metolazone Atenolol may increase the hypotensive activities of Metolazone. |
Secobarbital | Secobarbital The serum concentration of Atenolol can be decreased when it is combined with Secobarbital. |
Desipramine | Desipramine The metabolism of Desipramine can be decreased when combined with Atenolol. |
Amitriptyline | Amitriptyline The metabolism of Atenolol can be decreased when combined with Amitriptyline. |
Imipramine | Imipramine The metabolism of Imipramine can be decreased when combined with Atenolol. |
Quinidine | Quinidine Quinidine may increase the arrhythmogenic activities of Atenolol. |
Procainamide | Procainamide Atenolol may increase the arrhythmogenic activities of Procainamide. |
Rifampin | Rifampin The metabolism of Atenolol can be increased when combined with Rifampicin. |
Disopyramide | Disopyramide Disopyramide may increase the bradycardic activities of Atenolol. |
Tamoxifen | Tamoxifen The metabolism of Atenolol can be decreased when combined with Tamoxifen. |
Butabarbital | Butabarbital Butabarbital may increase the hypotensive activities of Atenolol. |
Levothyroxine | Levothyroxine The therapeutic efficacy of Levothyroxine can be decreased when used in combination with Atenolol. |
Liothyronine | Liothyronine The therapeutic efficacy of Liothyronine can be decreased when used in combination with Atenolol. |
Methimazole | Methimazole The excretion of Atenolol can be decreased when combined with Methimazole. |
Chlorpropamide | Chlorpropamide The therapeutic efficacy of Chlorpropamide can be increased when used in combination with Atenolol. |
Glucagon Injection | Glucagon Injection The therapeutic efficacy of Atenolol can be decreased when used in combination with Glucagon. |
Tolbutamide | Tolbutamide The therapeutic efficacy of Tolbutamide can be increased when used in combination with Atenolol. |
Tolazamide | Tolazamide The therapeutic efficacy of Tolazamide can be increased when used in combination with Atenolol. |
Dextromethorphan | Dextromethorphan The metabolism of Dextromethorphan can be decreased when combined with Atenolol. |
Niacin | Niacin The metabolism of Atenolol can be decreased when combined with Niacin. |
Baclofen | Baclofen The risk or severity of adverse effects can be increased when Baclofen is combined with Atenolol. |
Clemastine | Clemastine The metabolism of Atenolol can be decreased when combined with Clemastine. |
Chlorpheniramine | Chlorpheniramine The metabolism of Atenolol can be decreased when combined with Chlorpheniramine. |
Meclizine | Meclizine The metabolism of Meclizine can be decreased when combined with Atenolol. |
Methyclothiazide | Methyclothiazide The therapeutic efficacy of Atenolol can be increased when used in combination with Methyclothiazide. |
Hydrochlorothiazide | Hydrochlorothiazide The therapeutic efficacy of Hydrochlorothiazide can be increased when used in combination with Atenolol. |
Dantrolene | Dantrolene The risk or severity of hyperkalemia can be increased when Atenolol is combined with Dantrolene. |
Chlorzoxazone | Chlorzoxazone The metabolism of Chlorzoxazone can be decreased when combined with Atenolol. |
Disulfiram | Disulfiram Atenolol may decrease the excretion rate of Disulfiram which could result in a higher serum level. |
Propranolol (Cardiovascular) | Propranolol (Cardiovascular) Atenolol may increase the arrhythmogenic activities of Propranolol. |
Minoxidil | Minoxidil Atenolol may increase the hypotensive activities of Minoxidil. |
Pseudoephedrine | Pseudoephedrine The therapeutic efficacy of Atenolol can be decreased when used in combination with Pseudoephedrine. |
Nortriptyline | Nortriptyline The metabolism of Atenolol can be decreased when combined with Nortriptyline. |
Spironolactone | Spironolactone Atenolol may decrease the excretion rate of Spironolactone which could result in a higher serum level. |
Amphotericin B Injection | Amphotericin B Injection The risk or severity of adverse effects can be increased when Amphotericin B is combined with Atenolol. |
Mercaptopurine | Mercaptopurine The therapeutic efficacy of Mercaptopurine can be decreased when used in combination with Atenolol. |
Nadolol | Nadolol Atenolol may increase the arrhythmogenic activities of Nadolol. |
Papaverine | Papaverine The risk or severity of adverse effects can be increased when Papaverine is combined with Atenolol. |
Cefaclor | Cefaclor Atenolol may decrease the excretion rate of Cefaclor which could result in a higher serum level. |
Ketoconazole | Ketoconazole The metabolism of Atenolol can be decreased when combined with Ketoconazole. |
Thiotepa Injection | Thiotepa Injection Thiotepa may increase the bradycardic activities of Atenolol. |
Vincristine Injection | Vincristine Injection Atenolol may decrease the excretion rate of Vincristine which could result in a higher serum level. |
Captopril | Captopril The risk or severity of hyperkalemia can be increased when Atenolol is combined with Captopril. |
Dipyridamole | Dipyridamole Dipyridamole may increase the bradycardic activities of Atenolol. |
Isoxsuprine | Isoxsuprine The therapeutic efficacy of Isoxsuprine can be decreased when used in combination with Atenolol. |
Vinblastine | Vinblastine Vinblastine may decrease the excretion rate of Atenolol which could result in a higher serum level. |
Bethanechol | Bethanechol The risk or severity of adverse effects can be increased when Atenolol is combined with Bethanechol. |
Ethacrynic Acid | Ethacrynic Acid The risk or severity of adverse effects can be increased when Etacrynic acid is combined with Atenolol. |
Metoprolol | Metoprolol The metabolism of Atenolol can be decreased when combined with Metoprolol. |
Hydroxyzine | Hydroxyzine The metabolism of Atenolol can be decreased when combined with Hydroxyzine. |
Aspirin | Aspirin Acetylsalicylic acid may decrease the antihypertensive activities of Atenolol. |
Salsalate | Salsalate Salsalate may decrease the antihypertensive activities of Atenolol. |
Hyoscyamine | Hyoscyamine Atenolol may increase the arrhythmogenic activities of Hyoscyamine. |
Trimethoprim | Trimethoprim The risk or severity of hyperkalemia can be increased when Atenolol is combined with Trimethoprim. |
Diltiazem | Diltiazem The risk or severity of bradycardia can be increased when Diltiazem is combined with Atenolol. |
Nifedipine | Nifedipine The risk or severity of congestive heart failure and hypotension can be increased when Nifedipine is combined with Atenolol. |
Timolol | Timolol The risk or severity of adverse effects can be increased when Timolol is combined with Atenolol. |
Verapamil | Verapamil The risk or severity of adverse effects can be increased when Verapamil is combined with Atenolol. |
Pindolol | Pindolol The risk or severity of hyperkalemia can be increased when Atenolol is combined with Pindolol. |
Cisplatin Injection | Cisplatin Injection Cisplatin may increase the bradycardic activities of Atenolol. |
Diflunisal | Diflunisal Diflunisal may decrease the antihypertensive activities of Atenolol. |
Piroxicam | Piroxicam Piroxicam may decrease the antihypertensive activities of Atenolol. |
Bumetanide | Bumetanide The risk or severity of adverse effects can be increased when Bumetanide is combined with Atenolol. |
Glyburide | Glyburide The therapeutic efficacy of Atenolol can be increased when used in combination with Glyburide. |
Glipizide | Glipizide The therapeutic efficacy of Glipizide can be increased when used in combination with Atenolol. |
Indapamide | Indapamide The therapeutic efficacy of Indapamide can be increased when used in combination with Atenolol. |
Pentoxifylline | Pentoxifylline Pentoxifylline may increase the hypotensive activities of Atenolol. |
Pentamidine Injection | Pentamidine Injection The therapeutic efficacy of Pentamidine can be increased when used in combination with Atenolol. |
Labetalol | Labetalol Atenolol may increase the orthostatic hypotensive activities of Labetalol. |
Guanabenz | Guanabenz The therapeutic efficacy of Guanabenz can be decreased when used in combination with Atenolol. |
Ketoprofen | Ketoprofen Ketoprofen may decrease the antihypertensive activities of Atenolol. |
Pimozide | Pimozide The metabolism of Pimozide can be decreased when combined with Atenolol. |
Enalapril | Enalapril The risk or severity of hyperkalemia can be increased when Atenolol is combined with Enalapril. |
Flurbiprofen | Flurbiprofen Flurbiprofen may decrease the antihypertensive activities of Atenolol. |
Amiodarone | Amiodarone The therapeutic efficacy of Atenolol can be increased when used in combination with Amiodarone. |
Buspirone | Buspirone Buspirone may decrease the antihypertensive activities of Atenolol. |
Lovastatin | Lovastatin Lovastatin may decrease the excretion rate of Atenolol which could result in a higher serum level. |
Mesalamine | Mesalamine Mesalazine may decrease the antihypertensive activities of Atenolol. |
Diclofenac | Diclofenac Diclofenac may decrease the antihypertensive activities of Atenolol. |
Fluoxetine | Fluoxetine The serum concentration of Atenolol can be increased when it is combined with Fluoxetine. |
Nimodipine | Nimodipine The risk or severity of bradycardia can be increased when Nimodipine is combined with Atenolol. |
Clozapine | Clozapine The metabolism of Clozapine can be decreased when combined with Atenolol. |
Idarubicin | Idarubicin The metabolism of Idarubicin can be decreased when combined with Atenolol. |
Ofloxacin | Ofloxacin Atenolol may decrease the excretion rate of Ofloxacin which could result in a higher serum level. |
Clarithromycin | Clarithromycin Atenolol may decrease the excretion rate of Clarithromycin which could result in a higher serum level. |
Benazepril | Benazepril The risk or severity of hyperkalemia can be increased when Atenolol is combined with Benazepril. |
Etodolac | Etodolac Etodolac may decrease the antihypertensive activities of Atenolol. |
Felodipine | Felodipine The risk or severity of bradycardia can be increased when Felodipine is combined with Atenolol. |
Fosinopril | Fosinopril The risk or severity of hyperkalemia can be increased when Atenolol is combined with Fosinopril. |
Nabumetone | Nabumetone Nabumetone may decrease the antihypertensive activities of Atenolol. |
Pravastatin | Pravastatin Pravastatin may decrease the excretion rate of Atenolol which could result in a higher serum level. |
Quinapril | Quinapril The risk or severity of hyperkalemia can be increased when Atenolol is combined with Quinapril. |
Ramipril | Ramipril Ramipril may increase the hypotensive activities of Atenolol. |
Simvastatin | Simvastatin Atenolol may decrease the excretion rate of Simvastatin which could result in a higher serum level. |
Amlodipine | Amlodipine The risk or severity of bradycardia can be increased when Amlodipine is combined with Atenolol. |
Itraconazole | Itraconazole The risk or severity of hyperkalemia can be increased when Atenolol is combined with Itraconazole. |
Lisinopril | Lisinopril The risk or severity of hyperkalemia can be increased when Atenolol is combined with Lisinopril. |
Oxaprozin | Oxaprozin Oxaprozin may decrease the antihypertensive activities of Atenolol. |
Sotalol | Sotalol Atenolol may increase the arrhythmogenic activities of Sotalol. |
Bisoprolol | Bisoprolol The risk or severity of adverse effects can be increased when Bisoprolol is combined with Atenolol. |
Zolpidem | Zolpidem The metabolism of Zolpidem can be decreased when combined with Atenolol. |
Doxazosin | Doxazosin Atenolol may increase the orthostatic hypotensive activities of Doxazosin. |
Terazosin | Terazosin Atenolol may increase the orthostatic hypotensive activities of Terazosin. |
Isradipine | Isradipine The risk or severity of bradycardia can be increased when Isradipine is combined with Atenolol. |
Omeprazole | Omeprazole The metabolism of Atenolol can be decreased when combined with Omeprazole. |
Cisapride | Cisapride The metabolism of Atenolol can be decreased when combined with Cisapride. |
Fluvastatin | Fluvastatin The metabolism of Fluvastatin can be decreased when combined with Atenolol. |
Venlafaxine | Venlafaxine The metabolism of Atenolol can be decreased when combined with Venlafaxine. |
Nizatidine | Nizatidine Nizatidine may increase the bradycardic activities of Atenolol. |
Fluvoxamine | Fluvoxamine The metabolism of Atenolol can be decreased when combined with Fluvoxamine. |
Nefazodone | Nefazodone The serum concentration of Atenolol can be increased when it is combined with Nefazodone. |
Lamotrigine | Lamotrigine The risk or severity of bradycardia can be increased when Lamotrigine is combined with Atenolol. |
Losartan | Losartan Atenolol may increase the arrhythmogenic activities of Losartan. |
Tramadol | Tramadol The metabolism of Atenolol can be decreased when combined with Tramadol. |
Vinorelbine Injection | Vinorelbine Injection The metabolism of Atenolol can be decreased when combined with Vinorelbine. |
Moexipril | Moexipril The risk or severity of hyperkalemia can be increased when Atenolol is combined with Moexipril. |
Lansoprazole | Lansoprazole The metabolism of Atenolol can be decreased when combined with Lansoprazole. |
Nicardipine | Nicardipine The metabolism of Atenolol can be decreased when combined with Nicardipine. |
Bupropion | Bupropion The metabolism of Atenolol can be decreased when combined with Bupropion. |
Ticlopidine | Ticlopidine The metabolism of Atenolol can be decreased when combined with Ticlopidine. |
Saquinavir | Saquinavir Atenolol may decrease the excretion rate of Saquinavir which could result in a higher serum level. |
Metformin | Metformin The serum concentration of Metformin can be increased when it is combined with Atenolol. |
Dalteparin Injection | Dalteparin Injection The risk or severity of hyperkalemia can be increased when Atenolol is combined with Dalteparin. |
Nisoldipine | Nisoldipine The risk or severity of bradycardia can be increased when Nisoldipine is combined with Atenolol. |
Amifostine Injection | Amifostine Injection Atenolol may increase the hypotensive activities of Amifostine. |
Acarbose | Acarbose The therapeutic efficacy of Acarbose can be increased when used in combination with Atenolol. |
Glimepiride | Glimepiride Atenolol may increase the arrhythmogenic activities of Glimepiride. |
Indinavir | Indinavir Indinavir may decrease the excretion rate of Atenolol which could result in a higher serum level. |
Ritonavir | Ritonavir The metabolism of Atenolol can be decreased when combined with Ritonavir. |
Clomipramine | Clomipramine The metabolism of Atenolol can be decreased when combined with Clomipramine. |
Mirtazapine | Mirtazapine The metabolism of Mirtazapine can be decreased when combined with Atenolol. |
Trandolapril | Trandolapril The risk or severity of hyperkalemia can be increased when Atenolol is combined with Trandolapril. |
Valsartan | Valsartan The risk or severity of hyperkalemia can be increased when Valsartan is combined with Atenolol. |
Insulin Lispro Injection | Insulin Lispro Injection The therapeutic efficacy of Insulin lispro can be increased when used in combination with Atenolol. |
Pramipexole | Pramipexole The risk or severity of adverse effects can be increased when Pramipexole is combined with Atenolol. |
Donepezil | Donepezil Donepezil may increase the bradycardic activities of Atenolol. |
Nelfinavir | Nelfinavir The metabolism of Atenolol can be decreased when combined with Nelfinavir. |
Loratadine | Loratadine Atenolol may decrease the excretion rate of Loratadine which could result in a higher serum level. |
Carvedilol | Carvedilol The risk or severity of bradycardia can be increased when Atenolol is combined with Carvedilol. |
Selegiline | Selegiline Selegiline may increase the hypotensive activities of Atenolol. |
Bicalutamide | Bicalutamide The metabolism of Atenolol can be decreased when combined with Bicalutamide. |
Sertraline | Sertraline The serum concentration of Atenolol can be increased when it is combined with Sertraline. |
Propafenone | Propafenone The risk or severity of adverse effects can be increased when Propafenone is combined with Atenolol. |
Irbesartan | Irbesartan The risk or severity of hyperkalemia can be increased when Atenolol is combined with Irbesartan. |
Tamsulosin | Tamsulosin Atenolol may increase the orthostatic hypotensive activities of Tamsulosin. |
Ropinirole | Ropinirole The risk or severity of adverse effects can be increased when Ropinirole is combined with Atenolol. |
Finasteride | Finasteride Finasteride may decrease the antihypertensive activities of Atenolol. |
Quetiapine | Quetiapine Atenolol may increase the hypotensive activities of Quetiapine. |
Paroxetine | Paroxetine The metabolism of Atenolol can be decreased when combined with Paroxetine. |
Tolcapone | Tolcapone The risk or severity of adverse effects can be increased when Tolcapone is combined with Atenolol. |
Citalopram | Citalopram The metabolism of Atenolol can be decreased when combined with Citalopram. |
Efavirenz | Efavirenz Atenolol may decrease the excretion rate of Efavirenz which could result in a higher serum level. |
Sildenafil | Sildenafil Sildenafil may increase the antihypertensive activities of Atenolol. |
Pioglitazone | Pioglitazone The therapeutic efficacy of Pioglitazone can be increased when used in combination with Atenolol. |
Celecoxib | Celecoxib Celecoxib may decrease the antihypertensive activities of Atenolol. |
Rosiglitazone | Rosiglitazone The therapeutic efficacy of Atenolol can be increased when used in combination with Rosiglitazone. |
Tolterodine | Tolterodine The metabolism of Tolterodine can be decreased when combined with Atenolol. |
Thalidomide | Thalidomide The risk or severity of adverse effects can be increased when Thalidomide is combined with Atenolol. |
Balsalazide | Balsalazide Balsalazide may decrease the antihypertensive activities of Atenolol. |
Nateglinide | Nateglinide The therapeutic efficacy of Nateglinide can be increased when used in combination with Atenolol. |
Galantamine | Galantamine Galantamine may increase the bradycardic activities of Atenolol. |
Rabeprazole | Rabeprazole The metabolism of Atenolol can be decreased when combined with Rabeprazole. |
Terbinafine | Terbinafine The metabolism of Atenolol can be decreased when combined with Terbinafine. |
Content provided by: AHFS® Patient Medication Information™. © Copyright, 2021. The American Society of Health-System Pharmacists